Plain-English translation of NCT06939569 on ClinicalTrials.gov โ ยท Source last updated ยท Translation generated ยท
This is an observational study โ meaning researchers will follow you over time rather than test a new medication. Scientists want to understand how fatty liver disease (a buildup of fat in the liver) occurs in people with inflammatory bowel disease like Crohn's disease or ulcerative colitis, and whether having both conditions together affects how well current treatments work and what happens to patients long-term.
Doctors have noticed that many patients with inflammatory bowel disease also develop fatty liver disease, but no one has carefully studied how these two conditions interact or whether fatty liver disease makes bowel disease harder to treat. This research aims to answer those questions so doctors can better care for patients who have both conditions.
You likely qualify ifโฆ
You likely don't qualify ifโฆ
You will be asked to share your medical information and provide blood samples and possibly a small tissue sample from your intestines. Researchers will track your symptoms, test results, and overall health over time โ no new medications are involved. The study aims to enroll about 337 people total across multiple hospitals in China, and you would be followed to see how your bowel disease and liver health develop together.
AI-generated summary from trial data ยท Jun 18, 2026 ยท Not medical advice
China